The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016

Frances Oldham Kelsey papers, 1890-2016

Contact UsHelpSearch All Finding Aids
Access restrictions apply.Some or all content stored offsite.
ContainerContents
Part II: Subject File, 1902-2012 (continued)
BOX II:139 Eli Lilly and Co. Task Group See also Container II:100, Benoxaprofen ; Container II:128, Darvon ; Container II:136, Drobuline
BOX II:139 General, 1980-1981
BOX II:139 Report, 1983
(2 folders)
BOX II:139 Elixir sulfanilamide, 1967, 1983, circa 1993, 2002
BOX II:139 Ellenhorn, Matthew J., 1963, circa 1966, 1996-1999
BOX II:140 Enzymes, 1960-1962, 1996
BOX II:140 Epidemiology, 1962-1988, undated
(3 folders)
BOX II:140 Establishment Evaluation System
BOX II:140 Division of Scientific Investigations, flow charts and milestones, circa 1995-circa 1996
BOX II:140 General, 1995-1996
BOX II:140 Ethical consideration
BOX II:140 1965-1979
(2 folders)
BOX II:141 1980-1999, undated
BOX II:141 Ethical criteria, 1960-2001, undated
(5 folders)
BOX II:141 European Teratology Society, 1971-1977, 1994-2000
(2 folders)
BOX II:142 Executive Women in Government, 1994-1996
BOX II:142 Exempt drugs, 1979
BOX II:142 FDA Distinguished Alumni/Professor Emeritus Policy Task Force, 1998
BOX II:142 Federal Executive Professional Association, 1979-1986, 1998
BOX II:142 Feldene (piroxicam), 1983-1986
BOX II:142 Fetus and newborn, miscellaneous, 1961-1979, 1985-1986, undated
(2 folders)
BOX II:142 Fialuridine (FIAU), 1993-1994, 2001
BOX II:142 Flunixin, 1976-1977
BOX II:142 Folic acid, memorandum to John Patrick Swann with attachments, 1951-1952, 1963, 1995, undated
BOX II:143 Foreign clinical studies, U.S. Food and Drug Administration policy, 1973-1992, undated
(3 folders)
BOX II:143 Foreign travel requests, 1978-1982
BOX II:143 Foreign visitors, 1963-1968, 1979-1986, 1994-1997
BOX II:143 Fraud in science, cases and publicity
BOX II:143 circa 1961-1987
(4 folders)
BOX II:144 1988-1999, undated
(5 folders)
BOX II:144 Freedom of Information Act, correspondence and requests
BOX II:144 1977-1980
BOX II:145 1981-1987
BOX II:145 G. D. Searle & Co.
BOX II:145 Aldactone, 1975
BOX II:145 Aspartame/NutraSweet, 1983-1996, undated
BOX II:145 Copper-7, 1988, 1997
BOX II:145 Enovid/Ovulen, 1962, 1979
BOX II:145 Searle Investigation Task Force, 1975-1976, 1982-1985
(2 folders)
BOX II:145 Gene therapy, death in, 1980-1981, 1999-2000
BOX II:145 General Accounting Office
BOX II:145 Anticancer drugs, 1983
BOX II:145 General
BOX II:145 1973-1976
BOX II:146 1986-1990
BOX II:146 Generic drugs, 1987-1989
BOX II:146 Genetic factors, 1956-1990, undated
(6 folders)
BOX II:146 Gerovital, 1976-1980, 1999
BOX II:146 Gibson, William C., 1957-1963, 1996-2001
BOX II:146 “Ginger jake” affair, 1991-1994
BOX II:147 Good laboratory practices
BOX II:147 1964-1981
(9 folders)
BOX II:148 1982-1992, 1999, undated
(5 folders)
BOX II:148 Grecu, Eugen O., informal conference at U.S. Food and Drug Administration, transcript and exhibits, 1992
BOX II:148 Griseofulvin, 1963-1974, 1982-1988, undated
BOX II:148 Guidance for Industry: Providing Adequate Clinical Evidence of Effectiveness, draft, 1997
BOX II:149 Guidelines for clinical evaluations, printed matter, 1977-1980, 1987
(2 folders)
BOX II:149 Gulf War/Desert Storm, consent waivers and syndrome, 1992-2000
BOX II:149 Hayes, Arthur Hull, 1979-1983
(2 folders)
BOX II:149 Hayflick, Leonard, 1978-1982
BOX II:149 Heart tonic, 1965, 1997
BOX II:149 Hensley, Michael J., 1977-1981, 1999-2000
BOX II:149 Herbal remedies
BOX II:149 1992-1999
BOX II:150 2000-2002, undated
BOX II:150 Heroin and morphine, prenatal exposure and addiction, 1958-1990, 1999-2000, undated
(2 folders)
BOX II:150 Hexachloophene, 1972, 1978
BOX II:150 Hexobendine, 1973
BOX II:150 Historical material
BOX II:150 CDC capsules, press coverage, 1962
BOX II:150 Drug legislation, press coverage, 1962
BOX II:150 Federal regulations
BOX II:150 1960-1961
BOX II:150 1962
(1 folder)
BOX II:151 (1 folder)
BOX II:151 1963-1979
(6 folders)
BOX II:152 1980-1999, undated
(5 folders)
BOX II:152 General
BOX II:152 1902, 1918, 1928, 1934-1939, 1951-1961
(2 folders)
BOX II:153 1962-1964
(7 folders)
BOX II:154 1965-1974
(7 folders)
BOX II:155 1975-2005, undated
(7 folders)
BOX II:155 Micro-Dynameters and other topics, press coverage, 1962
BOX II:156 “News Items,” 1962
(2 folders)
BOX II:156 History competitions, requests for information and interviews, 1971, 1989-1999, undated
(2 folders)
BOX II:156 Homeopathy, 1962-1963, 1989-1997
BOX II:156 Hydrazine sulfate, 1976-1980, 1995-2000
BOX II:156 Hyperthermia and birth defects, 1966, 1973, 1980-1983, undated
BOX II:156 Hypoglycemic oral agents, 1963-1971, 1976-1984, 1998-2000
BOX II:157 Imipramine, 1963, 1969-1976, 1986
BOX II:157 Indocin, 1966, 2000
BOX II:157 Industrial Bio-Test Laboratories, Northbrook, Ill., 1977-1983, 2000-2001
BOX II:157 Influenza epidemic of 1918, 1982, 1997-2001
BOX II:157 Informed consent and patient consent See Containers II:157-II:164, Institutional review boards and consent
BOX II:157 Insecticides See Container II:186, Pesticides and environmental hazards
BOX II:157 Institutional review boards and consent
BOX II:157 Articles and clippings
BOX II:157 1961-1993
(5 folders)
BOX II:158 1996-2000, undated
Next Page »

Contents List